A set of ~800 largely isogenic deficiency stocks created by FLP-induced recombination between FRT-carrying transgenic insertions; molecularly defined deletion endpoints correspond to initial location of the progenitor insertions. Designed to fill gaps in deletion coverage and breakpoint placement; also used to replace older available deficiencies that have not been molecularly mapped.
Converted to release 5 coordinates from reported location in release 3 coordinates.
Sequence location of PBac{WH}sNPF[f06876].
The presence of P+PBac{XP5.WH5}BSC860 was verified using the PCR methods and primers described in FBrf0175003.
Exelixis, Inc. determined the insertion site of the progenitor P{XP}d05431 to be Release 3 genomic coordinate 20280511 on chromosome arm 2L. This corresponds to 38C5 on the Release 3 and Release 5 genome maps. The predicted position of the progenitor PBac{WH}sNPFf06876 on the Release 5 map is 38B1. Consequently, the cytological breakpoints of Df(2L)BSC860 are predicted to be 38B1;38C5.